ProBioGen partners with Granite Bio for cell line development and GMP manufacturing services
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
Subscribe To Our Newsletter & Stay Updated